Clinical Trials

30 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma in Situ, Hypertrophy, Motor Activity, Neoplasms

NCT05951179 2026-01-27

ADVANCED-2

Phase 2 Recruiting

131 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT04752722 2026-01-26

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Phase 1/2 Recruiting

350 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT07283835 2026-01-21

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Phase 2 Recruiting

16 enrolled

BreastDermatologicGenitourinaryGynecologicHead & NeckLymphoid

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ

NCT06022029 2025-12-24

ON-5001

Phase 1 Recruiting

168 enrolled

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Bites and Stings, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma in Situ, Uterine Cervical Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Skin Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Triple Negative Breast Neoplasms

NCT05014139 2025-11-20

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Phase 1 Terminated

37 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT04057209 2025-10-07

VoiceS

34 enrolled

Phase 2 Not yet recruiting

Carcinoma in Situ, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms

NCT07189793 2025-09-24

OHAI-NMIBC-01

106 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT04368247 2025-08-07

Skin Fluorescent Imaging (SFI) System in Patients With Nevi

GastrointestinalGynecologicOther hematologic neoplasmThoracic

300 enrolled

Carcinoma in Situ, Dysplastic Nevus Syndrome, Nevus

NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Recruiting

5,000 enrolled

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

NCT07092007 2025-07-29

NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer

18 enrolled

Phase 3 Active not recruiting

Carcinoma in Situ, Uterine Cervical Neoplasms

NCT03223753 2025-04-18

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

300 enrolled

Carcinoma in Situ

NCT03808818 2025-03-18

Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

306 enrolled 20 charts

Carcinoma in Situ, Neoplasms, Recurrence, Smoking Cessation

NCT05085977 2025-01-27

ADVANCED-1

Phase 1 Completed

12 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT05085990 2025-01-27

ADVANCED-1

Phase 1 Completed

10 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT02311959 2024-12-24

MAPAM-01

Phase 3 Completed

450 enrolled

Breast Neoplasms, Carcinoma in Situ

NCT06744140 2024-12-20

Role of MRI Breast in Detection of Ductal Carcinoma in Situ

Active not recruiting

35 enrolled

Carcinoma in Situ

NCT06741150 2024-12-18

NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.

18 enrolled

Carcinoma in Situ, Uterine Cervical Neoplasms

NCT04387461 2024-09-25

CORE-001

Phase 2 Completed

35 enrolled

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ

NCT01625260 2024-07-19

A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer

Phase 1/2 Terminated

12 enrolled 13 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Recurrence

NCT06389448 2024-05-07

Comparison of pCLE and EB in Gastric Lesion Diagnosis

366 enrolled

Gastrointestinal

Carcinoma in Situ, Stomach Neoplasms

NCT06324825 2024-03-22

Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial

144 enrolled

Carcinoma in Situ, Gastritis, Atrophic

NCT06056843 2023-10-02

PUD

Phase NA Unknown

150 enrolled

Breast Neoplasms, Carcinoma in Situ

NCT02486640 2023-07-24

BETAPREDICT

162 enrolled

Carcinoma in Situ, Multiple Sclerosis

NCT03268993 2023-04-07

Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer

6 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ, Head and Neck Neoplasms, Hyperplasia

NCT04312737 2023-01-06

EU-VALHUDES

600 enrolled

Carcinoma in Situ, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Neoplasms, Neoplasms by Histologic Type

NCT02698293 2022-11-22

PDT Plus Vitamin D3 for Anal Dysplasia

Phase 1 Withdrawn

Carcinoma in Situ

NCT02039388 2022-09-02

LUSTIC

Classical hematologyGynecologic

701 enrolled

Fanconi Anemia, Complementation Group D1, Carcinoma, Ovarian Epithelial, Carcinoma in Situ, Neoplasms, Ovarian Neoplasms

NCT04823871 2022-09-02

EHUD

406 enrolled

Carcinoma, Ovarian Epithelial, Carcinoma in Situ, Neoplasms, Ovarian Neoplasms

NCT02901548 2022-07-29

Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder

Phase 2 Terminated

17 enrolled 9 charts

Phase EARLY_PHASE1 Completed

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT03182959 2021-06-21

Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer

6 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ, Head and Neck Neoplasms, Hyperplasia

NCT01438112 2021-04-14

BOND

Phase 2/3 Terminated

22 enrolled

Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Virus Diseases

NCT04109092 2020-12-14

A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102

Phase 1 Withdrawn

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT00402779 2020-04-21

Erlotinib Prevention of Oral Cancer (EPOC)

Phase 3 Completed

303 enrolled 11 charts

Carcinoma in Situ, Mouth Neoplasms

NCT03134573 2019-03-26

PROmyBETAapp

96 enrolled

Carcinoma in Situ, Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting

NCT00260598 2018-09-13

LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer

Phase 2 Terminated

142 enrolled

Thoracic

Carcinoma in Situ, Carcinoma, Non-Small-Cell Lung, Pulmonary Disease, Chronic Obstructive

NCT03106610 2018-05-24

Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy

Phase 1 Terminated

1 enrolled

Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT02471495 2018-05-07

RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)

Phase 3 Withdrawn

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT01310803 2017-10-05

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Phase 3 Terminated

1 enrolled 5 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT01901991 2017-08-11

Localization of Nonpalpable Breast Lesions

410 enrolled

Breast Neoplasms, Carcinoma in Situ

NCT01052740 2017-07-02

X-Ray Mammography Standard of Care Protocol

108 enrolled

Breast Neoplasms, Carcinoma in Situ, Carcinoma, Intraductal, Noninfiltrating

NCT03195218 2017-06-22

UH3

Phase NA Unknown

1,780 enrolled